Wesfarmers (ASX:WES) share price rises on API takeover deal

Wesfarmers has agreed a deal for API…

| More on:
A close-up of a handshake depicting a business deal with one of the people in the background of the shot alongside a colleague looking pleased at the deal.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Wesfarmers Ltd (ASX: WES) share price is pushing higher on Monday following the release of an update on its takeover approach for Australian Pharmaceutical Industries Ltd (ASX: API).

At the time of writing, the conglomerate's shares are up slightly to $60.74.

Wesfarmers share price higher after takeover update

Investors have been bidding the Wesfarmers share price higher today after it reached an agreement with Priceline pharmacy chain operator Australian Pharmaceutical Industries (API).

According to the release, the two parties have entered into a scheme implementation deed (SID) under which it is proposed that Wesfarmers will acquire 100% of the shares in API that it does not already own via a scheme of arrangement.

Wesfarmers will be paying a cash consideration of $1.55 per API share, less any dividends that are paid. While this represents only a modest premium to the latest API share price, it is a 35.4% premium to its undisturbed closing share price on 9 July 2021.

What now?

The API Board is unanimously recommending that API shareholders vote in favour of the scheme, in the absence of a superior proposal and subject to the independent expert's report. Each director intends to vote all of the API shares held or controlled by them in favour of it.

The scheme remains subject to customary conditions, including API shareholder approval, court approval, ACCC approval, no material adverse change, and no prescribed occurrences. However, the scheme is not subject to due diligence or financing. The SID also contains exclusivity provisions for Wesfarmers and reciprocal break fees payable in certain circumstances.

Why acquire API?

Wesfarmers' Managing Director, Rob Scott, expects the acquisition of API to provide an attractive opportunity to enter the growing health, wellbeing, and beauty sector.

He said: "Wesfarmers continues to see opportunities to invest in and strengthen the competitive position of API and its community pharmacy partners by expanding ranges, improving supply chain capabilities and enhancing the online experience for customers."

Mr Scott also revealed that Wesfarmers will not be making any changes to API's community pharmacy model.

"In addition to our discussions with API management, we have engaged with industry stakeholders during due diligence. As we have previously stated, Wesfarmers supports the community pharmacy model, including the pharmacy ownership and location rules. Wesfarmers recognises the importance of strong relationships with our trading partners and we look forward to working closely with API's pharmacy partners, suppliers and other industry stakeholders," he added.

The Wesfarmers share price is up 18% in 2021.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Mergers & Acquisitions

A man sits in a chair hunched over a laptop and covered head to toe in frozen icicles to represent Envirosuite's trading halt
Mergers & Acquisitions

APM share price placed on ice as $1.8 billion deal goes dud

It's all question marks and raised eyebrows for shareholders of this ASX company today.

Read more »

Young man sitting at a table in front of a row of pokie machines staring intently at a laptop. looking at the Crown Resorts share price
Mergers & Acquisitions

Could Star Entertainment shares be next in line to catch a takeover bid?

Star shares have been battered, but could a buyout be coming?

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Bank Shares

Own CBA shares? Here's the tech stock the banking giant just invested in

CBA has made an interesting investment. Here's what you need to know.

Read more »

Man pointing at a blue rising share price graph.
Mergers & Acquisitions

Guess which ASX 300 stock is rocketing 10% on a $985 million cash bid!

Investors are piling into the ASX 300 stock on the back of a $985 million cash takeover bid.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Mergers & Acquisitions

Guess which ASX blue-chip share is throwing $202 million at another acquisition

This Aussie healthcare company is growing its presence in Switzerland.

Read more »

A man stands with his arms crossed in an X shape.
Mergers & Acquisitions

Boral share price falls after rejecting Seven Group takeover

The offer 'undervalues' Boral according to its committee.

Read more »

Miner looking at a tablet.
Materials Shares

Mineral Resources share price marching higher on new lithium project acquisition

ASX 200 investors are bidding up the Mineral Resources share price on Monday.

Read more »

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Technology Shares

Appen shares plunges 17% after takeover collapse

Well that didn't take long...

Read more »